1,7-phenanthroline has been researched along with tolfenamic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhazza, IM; Alwasel, S; Danko, M; Hudecova, L; Jomova, K; Kozovska, Z; Kucerova, L; Lauro, P; Moncol, J; Rajcaniova, S; Simunkova, M; Svorc, L; Valko, M | 1 |
1 other study(ies) available for 1,7-phenanthroline and tolfenamic acid
| Article | Year |
|---|---|
Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumi
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Biomimetic Materials; Cell Line, Tumor; Coordination Complexes; Copper; DNA; DNA Damage; Escherichia coli; Fenamates; Flufenamic Acid; Humans; Intercalating Agents; Mefenamic Acid; ortho-Aminobenzoates; Oxidation-Reduction; Phenanthrolines; Reactive Oxygen Species; Serum Albumin, Human; Superoxide Dismutase | 2019 |